Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury

Various hepatoxic factors, such as viruses, drugs, lipid deposition, and autoimmune responses, induce acute or chronic liver injury, and 3.5% of all worldwide deaths result from liver cirrhosis, liver failure, or hepatocellular carcinoma. Liver transplantation is currently limited by few liver donor...

Full description

Saved in:
Bibliographic Details
Published in:Stem cell research & therapy Vol. 11; no. 1; pp. 1 - 12
Main Authors: Hu, Chenxia, Zhao, Lingfei, Zhang, Lingjian, Bao, Qiongling, Li, Lanjuan
Format: Journal Article
Language:English
Published: London BioMed Central 03.09.2020
BioMed Central Ltd
Springer Nature B.V
BMC
Subjects:
ISSN:1757-6512, 1757-6512
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Various hepatoxic factors, such as viruses, drugs, lipid deposition, and autoimmune responses, induce acute or chronic liver injury, and 3.5% of all worldwide deaths result from liver cirrhosis, liver failure, or hepatocellular carcinoma. Liver transplantation is currently limited by few liver donors, expensive surgical costs, and severe immune rejection. Cell therapy, including hepatocyte transplantation and stem cell transplantation, has recently become an attractive option to reduce the overall need for liver transplantation and reduce the wait time for patients. Recent studies showed that mesenchymal stem cell (MSC) administration was a promising therapeutic approach for promoting liver regeneration and repairing liver injury by the migration of cells into liver sites, hepatogenic differentiation, immunoregulation, and paracrine mechanisms. MSCs secrete a large number of molecules into the extracellular space, and soluble proteins, free nucleic acids, lipids, and extracellular vesicles (EVs) effectively repair tissue injury in response to fluctuations in physiological states or pathological conditions. Cell-free-based therapies avoid the potential tumorigenicity, rejection of cells, emboli formation, undesired differentiation, and infection transmission of MSC transplantation. In this review, we focus on the potential mechanisms of MSC-based cell-free strategies for attenuating liver injury in various liver diseases. Secretome-mediated paracrine effects participate in the regulation of the hepatic immune microenvironment and promotion of hepatic epithelial repair. We look forward to completely reversing liver injury through an MSC-based cell-free strategy in regenerative medicine in the near future.
AbstractList Various hepatoxic factors, such as viruses, drugs, lipid deposition, and autoimmune responses, induce acute or chronic liver injury, and 3.5% of all worldwide deaths result from liver cirrhosis, liver failure, or hepatocellular carcinoma. Liver transplantation is currently limited by few liver donors, expensive surgical costs, and severe immune rejection. Cell therapy, including hepatocyte transplantation and stem cell transplantation, has recently become an attractive option to reduce the overall need for liver transplantation and reduce the wait time for patients. Recent studies showed that mesenchymal stem cell (MSC) administration was a promising therapeutic approach for promoting liver regeneration and repairing liver injury by the migration of cells into liver sites, hepatogenic differentiation, immunoregulation, and paracrine mechanisms. MSCs secrete a large number of molecules into the extracellular space, and soluble proteins, free nucleic acids, lipids, and extracellular vesicles (EVs) effectively repair tissue injury in response to fluctuations in physiological states or pathological conditions. Cell-free-based therapies avoid the potential tumorigenicity, rejection of cells, emboli formation, undesired differentiation, and infection transmission of MSC transplantation. In this review, we focus on the potential mechanisms of MSC-based cell-free strategies for attenuating liver injury in various liver diseases. Secretome-mediated paracrine effects participate in the regulation of the hepatic immune microenvironment and promotion of hepatic epithelial repair. We look forward to completely reversing liver injury through an MSC-based cell-free strategy in regenerative medicine in the near future. Keywords: Mesenchymal stem cell, Cell-free, Treatment, Liver injury, Cell death
Various hepatoxic factors, such as viruses, drugs, lipid deposition, and autoimmune responses, induce acute or chronic liver injury, and 3.5% of all worldwide deaths result from liver cirrhosis, liver failure, or hepatocellular carcinoma. Liver transplantation is currently limited by few liver donors, expensive surgical costs, and severe immune rejection. Cell therapy, including hepatocyte transplantation and stem cell transplantation, has recently become an attractive option to reduce the overall need for liver transplantation and reduce the wait time for patients. Recent studies showed that mesenchymal stem cell (MSC) administration was a promising therapeutic approach for promoting liver regeneration and repairing liver injury by the migration of cells into liver sites, hepatogenic differentiation, immunoregulation, and paracrine mechanisms. MSCs secrete a large number of molecules into the extracellular space, and soluble proteins, free nucleic acids, lipids, and extracellular vesicles (EVs) effectively repair tissue injury in response to fluctuations in physiological states or pathological conditions. Cell-free-based therapies avoid the potential tumorigenicity, rejection of cells, emboli formation, undesired differentiation, and infection transmission of MSC transplantation. In this review, we focus on the potential mechanisms of MSC-based cell-free strategies for attenuating liver injury in various liver diseases. Secretome-mediated paracrine effects participate in the regulation of the hepatic immune microenvironment and promotion of hepatic epithelial repair. We look forward to completely reversing liver injury through an MSC-based cell-free strategy in regenerative medicine in the near future.
Abstract Various hepatoxic factors, such as viruses, drugs, lipid deposition, and autoimmune responses, induce acute or chronic liver injury, and 3.5% of all worldwide deaths result from liver cirrhosis, liver failure, or hepatocellular carcinoma. Liver transplantation is currently limited by few liver donors, expensive surgical costs, and severe immune rejection. Cell therapy, including hepatocyte transplantation and stem cell transplantation, has recently become an attractive option to reduce the overall need for liver transplantation and reduce the wait time for patients. Recent studies showed that mesenchymal stem cell (MSC) administration was a promising therapeutic approach for promoting liver regeneration and repairing liver injury by the migration of cells into liver sites, hepatogenic differentiation, immunoregulation, and paracrine mechanisms. MSCs secrete a large number of molecules into the extracellular space, and soluble proteins, free nucleic acids, lipids, and extracellular vesicles (EVs) effectively repair tissue injury in response to fluctuations in physiological states or pathological conditions. Cell-free-based therapies avoid the potential tumorigenicity, rejection of cells, emboli formation, undesired differentiation, and infection transmission of MSC transplantation. In this review, we focus on the potential mechanisms of MSC-based cell-free strategies for attenuating liver injury in various liver diseases. Secretome-mediated paracrine effects participate in the regulation of the hepatic immune microenvironment and promotion of hepatic epithelial repair. We look forward to completely reversing liver injury through an MSC-based cell-free strategy in regenerative medicine in the near future.
Various hepatoxic factors, such as viruses, drugs, lipid deposition, and autoimmune responses, induce acute or chronic liver injury, and 3.5% of all worldwide deaths result from liver cirrhosis, liver failure, or hepatocellular carcinoma. Liver transplantation is currently limited by few liver donors, expensive surgical costs, and severe immune rejection. Cell therapy, including hepatocyte transplantation and stem cell transplantation, has recently become an attractive option to reduce the overall need for liver transplantation and reduce the wait time for patients. Recent studies showed that mesenchymal stem cell (MSC) administration was a promising therapeutic approach for promoting liver regeneration and repairing liver injury by the migration of cells into liver sites, hepatogenic differentiation, immunoregulation, and paracrine mechanisms. MSCs secrete a large number of molecules into the extracellular space, and soluble proteins, free nucleic acids, lipids, and extracellular vesicles (EVs) effectively repair tissue injury in response to fluctuations in physiological states or pathological conditions. Cell-free-based therapies avoid the potential tumorigenicity, rejection of cells, emboli formation, undesired differentiation, and infection transmission of MSC transplantation. In this review, we focus on the potential mechanisms of MSC-based cell-free strategies for attenuating liver injury in various liver diseases. Secretome-mediated paracrine effects participate in the regulation of the hepatic immune microenvironment and promotion of hepatic epithelial repair. We look forward to completely reversing liver injury through an MSC-based cell-free strategy in regenerative medicine in the near future.Various hepatoxic factors, such as viruses, drugs, lipid deposition, and autoimmune responses, induce acute or chronic liver injury, and 3.5% of all worldwide deaths result from liver cirrhosis, liver failure, or hepatocellular carcinoma. Liver transplantation is currently limited by few liver donors, expensive surgical costs, and severe immune rejection. Cell therapy, including hepatocyte transplantation and stem cell transplantation, has recently become an attractive option to reduce the overall need for liver transplantation and reduce the wait time for patients. Recent studies showed that mesenchymal stem cell (MSC) administration was a promising therapeutic approach for promoting liver regeneration and repairing liver injury by the migration of cells into liver sites, hepatogenic differentiation, immunoregulation, and paracrine mechanisms. MSCs secrete a large number of molecules into the extracellular space, and soluble proteins, free nucleic acids, lipids, and extracellular vesicles (EVs) effectively repair tissue injury in response to fluctuations in physiological states or pathological conditions. Cell-free-based therapies avoid the potential tumorigenicity, rejection of cells, emboli formation, undesired differentiation, and infection transmission of MSC transplantation. In this review, we focus on the potential mechanisms of MSC-based cell-free strategies for attenuating liver injury in various liver diseases. Secretome-mediated paracrine effects participate in the regulation of the hepatic immune microenvironment and promotion of hepatic epithelial repair. We look forward to completely reversing liver injury through an MSC-based cell-free strategy in regenerative medicine in the near future.
ArticleNumber 377
Audience Academic
Author Zhang, Lingjian
Hu, Chenxia
Bao, Qiongling
Zhao, Lingfei
Li, Lanjuan
Author_xml – sequence: 1
  givenname: Chenxia
  surname: Hu
  fullname: Hu, Chenxia
  organization: Collaborative Innovation Center for the Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, |The First Affiliated Hospital, School of Medicine, Zhejiang University, National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University
– sequence: 2
  givenname: Lingfei
  surname: Zhao
  fullname: Zhao, Lingfei
  organization: Kidney Disease Center, First Affiliated Hospital, College of Medicine, Zhejiang University, Key Laboratory of Kidney Disease Prevention and Control Technology, Institute of Nephrology, Zhejiang University
– sequence: 3
  givenname: Lingjian
  surname: Zhang
  fullname: Zhang, Lingjian
  organization: Collaborative Innovation Center for the Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, |The First Affiliated Hospital, School of Medicine, Zhejiang University, National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University
– sequence: 4
  givenname: Qiongling
  surname: Bao
  fullname: Bao, Qiongling
  organization: Collaborative Innovation Center for the Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, |The First Affiliated Hospital, School of Medicine, Zhejiang University, National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University
– sequence: 5
  givenname: Lanjuan
  surname: Li
  fullname: Li, Lanjuan
  email: ljli@zju.edu.cn
  organization: Collaborative Innovation Center for the Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, |The First Affiliated Hospital, School of Medicine, Zhejiang University, National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University
BookMark eNp9kltr3DAQhU1JadI0f6BPhkJpH5xKtmxLfSiE0MtCSqGXZ3UsjbxabCuR5ND999VmQxOHEuvBYvSdM8xwnmcHk5swy15Sckopb94FWpW8LUhJCkK5qAv6JDuibd0WTU3Lg3v3w-wkhA1JX1UR0rBn2WGS8qpi1VH2-ysGnNR6O8KQh4hjrnAYig4C6v3VeMT04iFibzG8zwMYzGHSORqDKtprzKNHiCNOMeTG-XxINZ_baTP77YvsqYEh4Mnt_zj79enjz_MvxcW3z6vzs4tCtbSOhaZMIGs1Ct01JSrWAWdCt4I3HDtQogHTAOWgq5p3FTGi1LVGZdJARCuojrPV3lc72MhLb0fwW-nAypuC870EH60aUAKnpdq1EKpjJZZcmUY0ouZAyppSTF4f9l6XczeiVmkwD8PCdPky2bXs3bVsWSPKlieDN7cG3l3NGKIcbdhtEyZ0c5AlY4Q1bcXqhL56gG7c7Ke0qh3FKBGEiTuqhzSAnYxLfdXOVJ41VU0YbQlL1Ol_qHQ0jlal_Bib6gvB24UgMRH_xB7mEOTqx_cl-_oeu0YY4jq4YY7WTWEJlntQeReCR_NvcZTIXXblPrsyZVfeZFfSJOIPRMpG2HmnEezwuLTaS0PqM_Xo7zb4iOovmksB3Q
CitedBy_id crossref_primary_10_1007_s00535_025_02262_8
crossref_primary_10_3389_fimmu_2022_865888
crossref_primary_10_1016_j_lfs_2023_121950
crossref_primary_10_1080_20477724_2022_2064795
crossref_primary_10_1177_09636897231184611
crossref_primary_10_1007_s44337_025_00339_0
crossref_primary_10_1186_s12951_022_01636_x
crossref_primary_10_1186_s12951_024_02455_y
crossref_primary_10_1681_ASN_0000000810
crossref_primary_10_3390_biomedicines10051049
crossref_primary_10_1007_s12015_025_10872_1
crossref_primary_10_1016_j_biopha_2024_116964
crossref_primary_10_3390_ijms23084135
crossref_primary_10_1007_s10142_024_01404_0
crossref_primary_10_1002_bit_28425
crossref_primary_10_1002_smll_202304824
crossref_primary_10_1093_rb_rbaf022
crossref_primary_10_3390_cells12010022
crossref_primary_10_3748_wjg_v27_i17_1905
crossref_primary_10_1155_2021_5513309
crossref_primary_10_2147_IJN_S450284
crossref_primary_10_3390_cells11213338
crossref_primary_10_1016_j_apsb_2025_04_022
crossref_primary_10_3389_fcell_2022_903740
crossref_primary_10_1186_s13287_022_02822_2
crossref_primary_10_3390_diseases10020030
crossref_primary_10_1007_s12015_022_10483_0
crossref_primary_10_1016_j_ijpharm_2025_125292
crossref_primary_10_2217_rme_2023_0089
crossref_primary_10_1016_j_pharmthera_2023_108563
crossref_primary_10_3389_fbioe_2023_1322514
crossref_primary_10_1016_j_biopha_2024_116133
crossref_primary_10_3390_cells11091408
crossref_primary_10_3390_ijms24119293
crossref_primary_10_1177_09636897231218383
crossref_primary_10_3389_fbioe_2024_1385931
crossref_primary_10_4252_wjsc_v14_i9_714
crossref_primary_10_1016_j_cej_2023_144729
crossref_primary_10_18502_ijrm_v22i10_17670
crossref_primary_10_3390_biomedicines11061736
crossref_primary_10_1016_j_cej_2024_155585
crossref_primary_10_4254_wjh_v13_i3_270
crossref_primary_10_1007_s11033_024_09878_8
crossref_primary_10_1007_s10616_023_00611_0
crossref_primary_10_3390_pharmaceutics14102208
crossref_primary_10_3389_fimmu_2025_1639455
crossref_primary_10_1016_j_apmt_2023_101785
crossref_primary_10_1038_s41419_021_04204_7
crossref_primary_10_1016_j_yexcr_2025_114750
crossref_primary_10_1186_s13287_022_03001_z
crossref_primary_10_1186_s13287_025_04535_8
crossref_primary_10_3389_fimmu_2022_1096402
crossref_primary_10_1111_liv_15739
crossref_primary_10_3389_fimmu_2023_1151322
crossref_primary_10_1186_s13287_022_03041_5
crossref_primary_10_1016_j_prp_2022_154280
crossref_primary_10_1007_s12072_024_10717_y
crossref_primary_10_3389_fmed_2021_655268
crossref_primary_10_1016_j_lfs_2023_121618
crossref_primary_10_3390_ijms23116273
crossref_primary_10_1002_rmv_2281
crossref_primary_10_1016_j_jhsa_2025_03_005
crossref_primary_10_3389_fphys_2022_909518
crossref_primary_10_1002_wnan_1915
crossref_primary_10_3390_biomedicines9111598
crossref_primary_10_3389_fmed_2024_1339573
crossref_primary_10_3389_fmicb_2021_804813
crossref_primary_10_3390_molecules28093842
crossref_primary_10_3390_ijms222413292
crossref_primary_10_3390_biology12050653
crossref_primary_10_1016_j_bcp_2021_114624
crossref_primary_10_1016_j_bcp_2024_116725
crossref_primary_10_1186_s13008_023_00104_8
crossref_primary_10_1016_j_ejphar_2024_176380
crossref_primary_10_1016_j_lfs_2025_123447
crossref_primary_10_1016_j_lfs_2023_121465
crossref_primary_10_1007_s40259_022_00555_5
crossref_primary_10_1021_acsami_4c19748
crossref_primary_10_20517_evcna_2025_08
crossref_primary_10_1007_s12672_025_03088_9
crossref_primary_10_1016_j_ijpharm_2021_120477
crossref_primary_10_1186_s13287_022_03054_0
crossref_primary_10_31083_j_fbl2812359
crossref_primary_10_1002_jcp_31008
crossref_primary_10_1016_j_bbrc_2021_10_078
crossref_primary_10_1186_s13287_023_03370_z
crossref_primary_10_3389_fphar_2022_787748
crossref_primary_10_1186_s13287_023_03350_3
crossref_primary_10_3390_metabo13030378
crossref_primary_10_1016_j_aanat_2023_152084
crossref_primary_10_1016_j_phrs_2021_105833
crossref_primary_10_1186_s12957_022_02867_w
Cites_doi 10.4161/auto.2229
10.1046/j.1439-0264.2002.00398.x
10.1016/j.jconrel.2019.07.021
10.3389/fimmu.2014.00148
10.1073/pnas.1521230113
10.1074/jbc.M114.588046
10.1016/j.jcyt.2013.03.005
10.1001/jamaoncol.2019.2996
10.1080/20013078.2019.1587567
10.1634/stemcells.2004-0331
10.2217/rme.13.71
10.1016/j.ymeth.2013.06.001
10.1016/j.mvr.2009.02.001
10.1016/j.cell.2006.07.024
10.1016/j.ymeth.2015.04.015
10.3389/fimmu.2012.00297
10.1186/s13287-019-1310-1
10.2147/HMER.S196354
10.2174/156652312802083594
10.1080/01926230701320337
10.1111/jcmm.13170
10.1002/hep.24305
10.7150/ijms.21666
10.3748/wjg.v20.i23.7312
10.1002/hep.26200
10.1002/stem.2298
10.1093/hmg/dds317
10.2217/rme.11.35
10.1155/2018/6079642
10.1016/j.ymthe.2016.11.019
10.1083/jcb.201504136
10.3109/14653249.2010.507330
10.1186/s12967-016-0792-1
10.1093/jrr/rrv026
10.1002/hep.21062
10.1186/s13287-019-1503-7
10.5966/sctm.2015-0191
10.1074/jbc.M109.041152
10.1016/j.arcmed.2013.03.006
10.1002/hep.20703
10.21037/atm.2020.03.218
10.21037/atm.2017.03.50
10.3402/jev.v2i0.21927
10.1371/journal.pone.0144678
10.1186/s12967-014-0260-8
10.1155/2012/971907
10.1186/s13287-019-1225-x
10.1080/14653240600855905
10.1038/nbt1374
10.1038/s41575-018-0065-y
10.1089/ten.teb.2009.0296
10.1634/stemcells.2005-0403
10.1016/j.ebiom.2018.08.054
10.1016/j.cyto.2018.07.032
10.1186/s13287-016-0453-6
10.1016/j.jhep.2018.09.014
10.1016/j.jss.2013.02.009
10.1159/000480533
10.1021/pr200682z
10.1038/srep36120
10.1371/journal.pone.0068451
10.1074/jbc.M112.439547
10.1038/nrgastro.2014.44
10.1186/s13287-019-1204-2
10.1016/j.bbrc.2018.11.189
10.1038/s12276-018-0142-x
10.1080/20013078.2018.1535750
10.1016/j.semcdb.2015.03.001
10.1111/j.1600-0854.2009.00920.x
10.1007/s13770-018-0160-8
10.3389/fcvm.2017.00063
10.1111/jth.12602
10.1007/s10528-018-9869-2
10.1007/s12015-016-9715-z
10.1186/s41232-016-0030-5
10.1155/2016/1929536
10.1016/j.molimm.2017.11.008
10.1055/s-2003-42639
10.1016/j.exer.2016.06.022
10.1089/scd.2012.0395
10.1002/hep.30056
10.1373/clinchem.2018.291963
10.1007/s11033-019-04765-z
10.1007/s00109-018-1638-5
10.1016/j.omtm.2018.12.003
10.1038/cddis.2016.1
10.1089/ten.tea.2011.0325
10.1136/gutjnl-2015-311146
10.3390/cells1041061
10.1038/nature07976
10.7150/thno.28021
10.1080/14779072.2019.1635012
10.1038/ncb1596
10.1038/mt.2015.44
10.15283/ijsc.2008.1.1.1
10.1016/j.bbamcr.2018.09.008
10.3402/jev.v3.24641
10.1177/019262339702500116
ContentType Journal Article
Copyright The Author(s) 2020
COPYRIGHT 2020 BioMed Central Ltd.
2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2020
– notice: COPYRIGHT 2020 BioMed Central Ltd.
– notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
ISR
3V.
7X7
7XB
88E
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s13287-020-01895-1
DatabaseName Springer Nature OA Free Journals
CrossRef
Gale In Context: Science
ProQuest Central (Corporate)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals (DOAJ)
DatabaseTitle CrossRef
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList





CrossRef
MEDLINE - Academic
Publicly Available Content Database

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1757-6512
EndPage 12
ExternalDocumentID oai_doaj_org_article_a812cec4b9cb42e28cf696958a02511e
PMC7469278
A635041704
10_1186_s13287_020_01895_1
GrantInformation_xml – fundername: National Natural Science Foundation of China
  grantid: 81700553
  funderid: http://dx.doi.org/10.13039/501100001809
– fundername: Zhejiang basic public welfare research program
  grantid: LGF20H030008
– fundername: Independent Fund of State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Zhejiang University
  grantid: N/A
– fundername: ;
  grantid: N/A
– fundername: ;
  grantid: 81700553
– fundername: ;
  grantid: LGF20H030008
GroupedDBID ---
0R~
53G
5VS
7X7
88E
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AASML
ABDBF
ABUWG
ACGFS
ACIHN
ACJQM
ACPRK
ACUHS
ADBBV
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIAM
AOIJS
BAPOH
BAWUL
BBNVY
BCNDV
BENPR
BFQNJ
BHPHI
BMC
BPHCQ
BVXVI
C6C
CCPQU
DIK
E3Z
EBD
EBLON
EBS
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IEA
IHR
IHW
INH
INR
ISR
ITC
KQ8
LK8
M1P
M7P
M~E
O5R
O5S
OK1
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
PUEGO
RBZ
ROL
RPM
RSV
SBL
SOJ
SV3
TUS
UKHRP
AAYXX
AFFHD
CITATION
ALIPV
3V.
7XB
8FK
AZQEC
DWQXO
GNUQQ
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c715t-d149e47de9db62ec4ba849d79868ebac96af6a18ad358b30f92d5decf0640dca3
IEDL.DBID M7P
ISICitedReferencesCount 110
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000568563000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1757-6512
IngestDate Fri Oct 03 12:45:54 EDT 2025
Tue Nov 04 01:59:58 EST 2025
Sun Nov 09 14:35:41 EST 2025
Tue Oct 21 14:13:32 EDT 2025
Tue Nov 11 10:14:34 EST 2025
Tue Nov 04 17:51:09 EST 2025
Thu Nov 13 15:15:30 EST 2025
Thu May 22 21:19:45 EDT 2025
Sat Nov 29 01:46:18 EST 2025
Tue Nov 18 22:20:51 EST 2025
Sat Sep 06 07:28:27 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Mesenchymal stem cell
Cell-free
Treatment
Cell death
Liver injury
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c715t-d149e47de9db62ec4ba849d79868ebac96af6a18ad358b30f92d5decf0640dca3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
OpenAccessLink https://www.proquest.com/docview/2444109049?pq-origsite=%requestingapplication%
PMID 32883343
PQID 2444109049
PQPubID 2040189
PageCount 12
ParticipantIDs doaj_primary_oai_doaj_org_article_a812cec4b9cb42e28cf696958a02511e
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7469278
proquest_miscellaneous_2440467345
proquest_journals_2444109049
gale_infotracmisc_A635041704
gale_infotracacademiconefile_A635041704
gale_incontextgauss_ISR_A635041704
gale_healthsolutions_A635041704
crossref_primary_10_1186_s13287_020_01895_1
crossref_citationtrail_10_1186_s13287_020_01895_1
springer_journals_10_1186_s13287_020_01895_1
PublicationCentury 2000
PublicationDate 2020-09-03
PublicationDateYYYYMMDD 2020-09-03
PublicationDate_xml – month: 09
  year: 2020
  text: 2020-09-03
  day: 03
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
PublicationTitle Stem cell research & therapy
PublicationTitleAbbrev Stem Cell Res Ther
PublicationYear 2020
Publisher BioMed Central
BioMed Central Ltd
Springer Nature B.V
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: Springer Nature B.V
– name: BMC
References SK Asrani (1895_CR3) 2019; 70
D Furlani (1895_CR20) 2009; 77
AA Kiani (1895_CR94) 2013; 44
S Rodriguez-Enriquez (1895_CR37) 2006; 2
1895_CR47
C Salomon (1895_CR61) 2013; 8
L Chen (1895_CR98) 2018; 2018
A Lindenmair (1895_CR11) 2012; 1
T Li (1895_CR89) 2013; 22
1895_CR30
A La Greca (1895_CR58) 2018; 50
1895_CR35
Y Kabe (1895_CR69) 2018; 64
J Polson (1895_CR31) 2005; 41
L Chen (1895_CR101) 2018; 93
DJ Prockop (1895_CR17) 2010; 12
YH Kim (1895_CR82) 2019; 16
YS Chen (1895_CR71) 2019; 32
A Eirin (1895_CR60) 2016; 6
1895_CR22
1895_CR21
B Zhang (1895_CR64) 2016; 2016
A Kurtz (1895_CR15) 2008; 1
D Shi (1895_CR9) 2017; 66
Y Liu (1895_CR90) 2018; 36
J Kowal (1895_CR74) 2016; 113
SC Lee (1895_CR96) 2016; 5
PA Sotiropoulou (1895_CR19) 2006; 24
A Görgens (1895_CR70) 2019; 8
SM Riordan (1895_CR33) 2003; 23
RF Schwabe (1895_CR44) 2018; 15
XX Yang (1895_CR65) 2019; 308
GK Michalopoulos (1895_CR34) 2005; 93
MA Bermudez (1895_CR25) 2016; 149
M Miceli (1895_CR5) 2019; 17
WC Zhou (1895_CR29) 2014; 20
AB Angulski (1895_CR56) 2017; 13
I Parolini (1895_CR54) 2009; 284
H Valadi (1895_CR100) 2007; 9
V Volarevic (1895_CR14) 2018; 15
AJ O'Loughlin (1895_CR24) 2012; 12
S Zhang (1895_CR2) 2020; 8
R Singh (1895_CR38) 2009; 458
C Hu (1895_CR28) 2019; 10
S Elmore (1895_CR40) 2007; 35
BF Trump (1895_CR43) 1997; 25
L Chen (1895_CR86) 2017; 8
1895_CR87
X Rong (1895_CR88) 2019; 10
CK Sun (1895_CR99) 2017; 9
M Osugi (1895_CR26) 2012; 18
C Hu (1895_CR10) 2016; 7
S Roychowdhury (1895_CR36) 2013; 57
A Temnov (1895_CR95) 2019; 11
T Tian (1895_CR52) 2014; 289
Y Yan (1895_CR91) 2017; 25
Y Lee (1895_CR75) 2012; 21
L Jiang (1895_CR85) 2019; 508
M Dominici (1895_CR13) 2006; 8
M Nakagawa (1895_CR7) 2008; 26
JD Anderson (1895_CR57) 2016; 34
C Fitzmaurice (1895_CR76) 2019; 5
KE Hawkins (1895_CR93) 2013; 8
YX Chen (1895_CR79) 2015; 56
C Théry (1895_CR72) 2018; 7
R Tamura (1895_CR83) 2016; 36
R Das (1895_CR92) 2010; 16
SJ Forbes (1895_CR4) 2014; 11
M Miura (1895_CR18) 2006; 24
JS Bajaj (1895_CR32) 2018; 68
S Stuffers (1895_CR73) 2009; 10
B Huang (1895_CR81) 2016; 14
N Pacienza (1895_CR78) 2019; 13
LP Zhu (1895_CR63) 2018; 8
RC Lai (1895_CR50) 2015; 40
CA Lee (1895_CR1) 2018; 96
Z Nizamudeen (1895_CR68) 2018; 1865
H Malhi (1895_CR39) 2006; 43
L Chen (1895_CR12) 2019; 10
V Hyenne (1895_CR48) 2015; 211
Z Du (1895_CR80) 2013; 183
1895_CR62
RC Lai (1895_CR59) 2012; 2012
C Hu (1895_CR8) 2019; 10
X Yang (1895_CR27) 2019; 57
C Sanz-Garcia (1895_CR46) 2013; 288
SJ Martin (1895_CR45) 2013; 61
E van der Pol (1895_CR66) 2014; 12
L Barkholt (1895_CR16) 2013; 15
S Van Cruchten (1895_CR41) 2002; 31
GR Willis (1895_CR77) 2017; 4
S Rani (1895_CR103) 2015; 23
KM Danielson (1895_CR67) 2016; 11
1895_CR53
L Beer (1895_CR23) 2017; 5
MF Peterson (1895_CR49) 2015; 87
AA Temnov (1895_CR97) 2019; 46
Y Du (1895_CR84) 2017; 43
K Takahashi (1895_CR6) 2006; 126
RC Lai (1895_CR51) 2011; 6
HS Kim (1895_CR55) 2012; 11
Y Qu (1895_CR102) 2017; 21
H Hikita (1895_CR42) 2011; 54
References_xml – volume: 2
  start-page: 39
  issue: 1
  year: 2006
  ident: 1895_CR37
  publication-title: Autophagy.
  doi: 10.4161/auto.2229
– volume: 31
  start-page: 214
  issue: 4
  year: 2002
  ident: 1895_CR41
  publication-title: Anat Histol Embryol
  doi: 10.1046/j.1439-0264.2002.00398.x
– volume: 308
  start-page: 119
  year: 2019
  ident: 1895_CR65
  publication-title: J Control Release
  doi: 10.1016/j.jconrel.2019.07.021
– ident: 1895_CR21
  doi: 10.3389/fimmu.2014.00148
– volume: 113
  start-page: E968
  issue: 8
  year: 2016
  ident: 1895_CR74
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1521230113
– volume: 289
  start-page: 22258
  issue: 32
  year: 2014
  ident: 1895_CR52
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M114.588046
– volume: 15
  start-page: 753
  issue: 7
  year: 2013
  ident: 1895_CR16
  publication-title: Cytotherapy.
  doi: 10.1016/j.jcyt.2013.03.005
– volume: 5
  start-page: 1749
  issue: 12
  year: 2019
  ident: 1895_CR76
  publication-title: JAMA Oncol
  doi: 10.1001/jamaoncol.2019.2996
– volume: 8
  start-page: 1587567
  issue: 1
  year: 2019
  ident: 1895_CR70
  publication-title: J Extracell Vesicles
  doi: 10.1080/20013078.2019.1587567
– volume: 24
  start-page: 462
  issue: 2
  year: 2006
  ident: 1895_CR19
  publication-title: Stem Cells
  doi: 10.1634/stemcells.2004-0331
– volume: 8
  start-page: 771
  issue: 6
  year: 2013
  ident: 1895_CR93
  publication-title: Regen Med
  doi: 10.2217/rme.13.71
– volume: 61
  start-page: 87
  issue: 2
  year: 2013
  ident: 1895_CR45
  publication-title: Methods.
  doi: 10.1016/j.ymeth.2013.06.001
– volume: 77
  start-page: 370
  issue: 3
  year: 2009
  ident: 1895_CR20
  publication-title: Microvasc Res
  doi: 10.1016/j.mvr.2009.02.001
– volume: 126
  start-page: 663
  issue: 4
  year: 2006
  ident: 1895_CR6
  publication-title: Cell.
  doi: 10.1016/j.cell.2006.07.024
– volume: 87
  start-page: 31
  year: 2015
  ident: 1895_CR49
  publication-title: Methods.
  doi: 10.1016/j.ymeth.2015.04.015
– ident: 1895_CR22
  doi: 10.3389/fimmu.2012.00297
– volume: 10
  start-page: 199
  issue: 1
  year: 2019
  ident: 1895_CR8
  publication-title: Stem Cell Res Ther
  doi: 10.1186/s13287-019-1310-1
– volume: 11
  start-page: 89
  year: 2019
  ident: 1895_CR95
  publication-title: Hepat Med
  doi: 10.2147/HMER.S196354
– volume: 12
  start-page: 262
  issue: 4
  year: 2012
  ident: 1895_CR24
  publication-title: Curr Gene Ther
  doi: 10.2174/156652312802083594
– volume: 35
  start-page: 495
  issue: 4
  year: 2007
  ident: 1895_CR40
  publication-title: Toxicol Pathol
  doi: 10.1080/01926230701320337
– volume: 21
  start-page: 2491
  issue: 10
  year: 2017
  ident: 1895_CR102
  publication-title: J Cell Mol Med
  doi: 10.1111/jcmm.13170
– volume: 54
  start-page: 240
  issue: 1
  year: 2011
  ident: 1895_CR42
  publication-title: Hepatology.
  doi: 10.1002/hep.24305
– volume: 15
  start-page: 36
  issue: 1
  year: 2018
  ident: 1895_CR14
  publication-title: Int J Med Sci
  doi: 10.7150/ijms.21666
– volume: 20
  start-page: 7312
  issue: 23
  year: 2014
  ident: 1895_CR29
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v20.i23.7312
– volume: 57
  start-page: 1773
  issue: 5
  year: 2013
  ident: 1895_CR36
  publication-title: Hepatology.
  doi: 10.1002/hep.26200
– volume: 34
  start-page: 601
  issue: 3
  year: 2016
  ident: 1895_CR57
  publication-title: Stem Cells
  doi: 10.1002/stem.2298
– volume: 21
  start-page: R125
  issue: R1
  year: 2012
  ident: 1895_CR75
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/dds317
– volume: 6
  start-page: 481
  issue: 4
  year: 2011
  ident: 1895_CR51
  publication-title: Regen Med
  doi: 10.2217/rme.11.35
– ident: 1895_CR87
  doi: 10.1155/2018/6079642
– volume: 25
  start-page: 465
  issue: 2
  year: 2017
  ident: 1895_CR91
  publication-title: Mol Ther
  doi: 10.1016/j.ymthe.2016.11.019
– volume: 211
  start-page: 27
  issue: 1
  year: 2015
  ident: 1895_CR48
  publication-title: J Cell Biol
  doi: 10.1083/jcb.201504136
– volume: 12
  start-page: 576
  issue: 5
  year: 2010
  ident: 1895_CR17
  publication-title: Cytotherapy.
  doi: 10.3109/14653249.2010.507330
– volume: 14
  start-page: 45
  year: 2016
  ident: 1895_CR81
  publication-title: J Transl Med
  doi: 10.1186/s12967-016-0792-1
– volume: 56
  start-page: 700
  issue: 4
  year: 2015
  ident: 1895_CR79
  publication-title: J Radiat Res
  doi: 10.1093/jrr/rrv026
– volume: 43
  start-page: S31
  issue: 2 Suppl 1
  year: 2006
  ident: 1895_CR39
  publication-title: Hepatology.
  doi: 10.1002/hep.21062
– volume: 10
  start-page: 406
  issue: 1
  year: 2019
  ident: 1895_CR12
  publication-title: Stem Cell Res Ther
  doi: 10.1186/s13287-019-1503-7
– volume: 5
  start-page: 816
  issue: 6
  year: 2016
  ident: 1895_CR96
  publication-title: Stem Cells Transl Med
  doi: 10.5966/sctm.2015-0191
– volume: 284
  start-page: 34211
  issue: 49
  year: 2009
  ident: 1895_CR54
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M109.041152
– volume: 32
  start-page: 113
  issue: 2
  year: 2019
  ident: 1895_CR71
  publication-title: Ci Ji Yi Xue Za Zhi
– volume: 44
  start-page: 185
  issue: 3
  year: 2013
  ident: 1895_CR94
  publication-title: Arch Med Res
  doi: 10.1016/j.arcmed.2013.03.006
– volume: 41
  start-page: 1179
  issue: 5
  year: 2005
  ident: 1895_CR31
  publication-title: Hepatology.
  doi: 10.1002/hep.20703
– volume: 8
  start-page: 565
  issue: 8
  year: 2020
  ident: 1895_CR2
  publication-title: Ann Transl Med
  doi: 10.21037/atm.2020.03.218
– volume: 5
  start-page: 170
  issue: 7
  year: 2017
  ident: 1895_CR23
  publication-title: Ann Transl Med
  doi: 10.21037/atm.2017.03.50
– ident: 1895_CR62
  doi: 10.3402/jev.v2i0.21927
– volume: 11
  start-page: e0144678
  issue: 1
  year: 2016
  ident: 1895_CR67
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0144678
– ident: 1895_CR47
  doi: 10.1186/s12967-014-0260-8
– volume: 2012
  start-page: 971907
  year: 2012
  ident: 1895_CR59
  publication-title: Int J Proteomics
  doi: 10.1155/2012/971907
– volume: 10
  start-page: 120
  issue: 1
  year: 2019
  ident: 1895_CR28
  publication-title: Stem Cell Res Ther
  doi: 10.1186/s13287-019-1225-x
– volume: 8
  start-page: 315
  issue: 4
  year: 2006
  ident: 1895_CR13
  publication-title: Cytotherapy.
  doi: 10.1080/14653240600855905
– volume: 26
  start-page: 101
  issue: 1
  year: 2008
  ident: 1895_CR7
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt1374
– volume: 15
  start-page: 738
  issue: 12
  year: 2018
  ident: 1895_CR44
  publication-title: Nat Rev Gastroenterol Hepatol
  doi: 10.1038/s41575-018-0065-y
– volume: 9
  start-page: 1543
  issue: 4
  year: 2017
  ident: 1895_CR99
  publication-title: Am J Transl Res
– volume: 16
  start-page: 159
  issue: 2
  year: 2010
  ident: 1895_CR92
  publication-title: Tissue Eng Part B Rev
  doi: 10.1089/ten.teb.2009.0296
– volume: 24
  start-page: 1095
  issue: 4
  year: 2006
  ident: 1895_CR18
  publication-title: Stem Cells
  doi: 10.1634/stemcells.2005-0403
– volume: 36
  start-page: 140
  year: 2018
  ident: 1895_CR90
  publication-title: EBioMed
  doi: 10.1016/j.ebiom.2018.08.054
– ident: 1895_CR30
  doi: 10.1016/j.cyto.2018.07.032
– volume: 8
  start-page: 9
  issue: 1
  year: 2017
  ident: 1895_CR86
  publication-title: Stem Cell Res Ther
  doi: 10.1186/s13287-016-0453-6
– volume: 70
  start-page: 151
  issue: 1
  year: 2019
  ident: 1895_CR3
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2018.09.014
– volume: 183
  start-page: 907
  issue: 2
  year: 2013
  ident: 1895_CR80
  publication-title: J Surg Res
  doi: 10.1016/j.jss.2013.02.009
– volume: 43
  start-page: 611
  issue: 2
  year: 2017
  ident: 1895_CR84
  publication-title: Cell Physiol Biochem
  doi: 10.1159/000480533
– volume: 11
  start-page: 839
  issue: 2
  year: 2012
  ident: 1895_CR55
  publication-title: J Proteome Res
  doi: 10.1021/pr200682z
– volume: 6
  start-page: 36120
  year: 2016
  ident: 1895_CR60
  publication-title: Sci Rep
  doi: 10.1038/srep36120
– volume: 8
  start-page: e68451
  issue: 7
  year: 2013
  ident: 1895_CR61
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0068451
– volume: 288
  start-page: 15342
  issue: 21
  year: 2013
  ident: 1895_CR46
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M112.439547
– volume: 11
  start-page: 277
  issue: 5
  year: 2014
  ident: 1895_CR4
  publication-title: Nat Rev Gastroenterol Hepatol.
  doi: 10.1038/nrgastro.2014.44
– volume: 10
  start-page: 98
  issue: 1
  year: 2019
  ident: 1895_CR88
  publication-title: Stem Cell Res Ther
  doi: 10.1186/s13287-019-1204-2
– volume: 508
  start-page: 735
  issue: 3
  year: 2019
  ident: 1895_CR85
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2018.11.189
– volume: 50
  start-page: 119
  issue: 9
  year: 2018
  ident: 1895_CR58
  publication-title: Exp Mol Med
  doi: 10.1038/s12276-018-0142-x
– volume: 7
  start-page: 1535750
  issue: 1
  year: 2018
  ident: 1895_CR72
  publication-title: J Extracell Vesicles
  doi: 10.1080/20013078.2018.1535750
– volume: 40
  start-page: 82
  year: 2015
  ident: 1895_CR50
  publication-title: Semin Cell Dev Biol
  doi: 10.1016/j.semcdb.2015.03.001
– volume: 10
  start-page: 925
  issue: 7
  year: 2009
  ident: 1895_CR73
  publication-title: Traffic.
  doi: 10.1111/j.1600-0854.2009.00920.x
– volume: 16
  start-page: 51
  issue: 1
  year: 2019
  ident: 1895_CR82
  publication-title: Tissue Eng Regen Med
  doi: 10.1007/s13770-018-0160-8
– volume: 4
  start-page: 63
  year: 2017
  ident: 1895_CR77
  publication-title: Front Cardiovasc Med
  doi: 10.3389/fcvm.2017.00063
– volume: 12
  start-page: 1182
  issue: 7
  year: 2014
  ident: 1895_CR66
  publication-title: J Thromb Haemost
  doi: 10.1111/jth.12602
– volume: 57
  start-page: 1
  issue: 1
  year: 2019
  ident: 1895_CR27
  publication-title: Biochem Genet
  doi: 10.1007/s10528-018-9869-2
– volume: 13
  start-page: 244
  issue: 2
  year: 2017
  ident: 1895_CR56
  publication-title: Stem Cell Rev Rep
  doi: 10.1007/s12015-016-9715-z
– volume: 36
  start-page: 26
  year: 2016
  ident: 1895_CR83
  publication-title: Inflamm Regen
  doi: 10.1186/s41232-016-0030-5
– ident: 1895_CR35
– volume: 2016
  start-page: 1929536
  year: 2016
  ident: 1895_CR64
  publication-title: Stem Cells Int
  doi: 10.1155/2016/1929536
– volume: 93
  start-page: 38
  year: 2018
  ident: 1895_CR101
  publication-title: Mol Immunol
  doi: 10.1016/j.molimm.2017.11.008
– volume: 2018
  start-page: 9156560
  year: 2018
  ident: 1895_CR98
  publication-title: Stem Cells Int
– volume: 23
  start-page: 203
  issue: 3
  year: 2003
  ident: 1895_CR33
  publication-title: Semin Liver Dis
  doi: 10.1055/s-2003-42639
– volume: 149
  start-page: 84
  year: 2016
  ident: 1895_CR25
  publication-title: Exp Eye Res
  doi: 10.1016/j.exer.2016.06.022
– volume: 22
  start-page: 845
  issue: 6
  year: 2013
  ident: 1895_CR89
  publication-title: Stem Cells Dev
  doi: 10.1089/scd.2012.0395
– volume: 68
  start-page: 1621
  issue: 4
  year: 2018
  ident: 1895_CR32
  publication-title: Hepatology.
  doi: 10.1002/hep.30056
– volume: 64
  start-page: 1463
  issue: 10
  year: 2018
  ident: 1895_CR69
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2018.291963
– volume: 46
  start-page: 3101
  issue: 3
  year: 2019
  ident: 1895_CR97
  publication-title: Mol Biol Rep
  doi: 10.1007/s11033-019-04765-z
– volume: 96
  start-page: 469
  issue: 6
  year: 2018
  ident: 1895_CR1
  publication-title: J Mol Med (Berl)
  doi: 10.1007/s00109-018-1638-5
– volume: 13
  start-page: 67
  year: 2019
  ident: 1895_CR78
  publication-title: Mol Ther Methods Clin Dev
  doi: 10.1016/j.omtm.2018.12.003
– volume: 7
  start-page: e2141
  issue: 3
  year: 2016
  ident: 1895_CR10
  publication-title: Cell Death Dis
  doi: 10.1038/cddis.2016.1
– volume: 93
  start-page: 101
  year: 2005
  ident: 1895_CR34
  publication-title: Adv Biochem Eng Biotechnol
– volume: 18
  start-page: 1479
  issue: 13–14
  year: 2012
  ident: 1895_CR26
  publication-title: Tissue Eng Part A
  doi: 10.1089/ten.tea.2011.0325
– volume: 66
  start-page: 955
  issue: 5
  year: 2017
  ident: 1895_CR9
  publication-title: Gut.
  doi: 10.1136/gutjnl-2015-311146
– volume: 1
  start-page: 1061
  issue: 4
  year: 2012
  ident: 1895_CR11
  publication-title: Cells.
  doi: 10.3390/cells1041061
– volume: 458
  start-page: 1131
  issue: 7242
  year: 2009
  ident: 1895_CR38
  publication-title: Nature.
  doi: 10.1038/nature07976
– volume: 8
  start-page: 6163
  issue: 22
  year: 2018
  ident: 1895_CR63
  publication-title: Theranostics.
  doi: 10.7150/thno.28021
– volume: 17
  start-page: 511
  issue: 7
  year: 2019
  ident: 1895_CR5
  publication-title: Expert Rev Cardiovasc Ther
  doi: 10.1080/14779072.2019.1635012
– volume: 9
  start-page: 654
  issue: 6
  year: 2007
  ident: 1895_CR100
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb1596
– volume: 23
  start-page: 812
  issue: 5
  year: 2015
  ident: 1895_CR103
  publication-title: Mol Ther
  doi: 10.1038/mt.2015.44
– volume: 1
  start-page: 1
  issue: 1
  year: 2008
  ident: 1895_CR15
  publication-title: Int J Stem Cells
  doi: 10.15283/ijsc.2008.1.1.1
– volume: 1865
  start-page: 1891
  issue: 12
  year: 2018
  ident: 1895_CR68
  publication-title: Biochim Biophys Acta Mol Cell Res
  doi: 10.1016/j.bbamcr.2018.09.008
– ident: 1895_CR53
  doi: 10.3402/jev.v3.24641
– volume: 25
  start-page: 82
  issue: 1
  year: 1997
  ident: 1895_CR43
  publication-title: Toxicol Pathol
  doi: 10.1177/019262339702500116
SSID ssj0000330064
Score 2.5440028
SecondaryResourceType review_article
Snippet Various hepatoxic factors, such as viruses, drugs, lipid deposition, and autoimmune responses, induce acute or chronic liver injury, and 3.5% of all worldwide...
Abstract Various hepatoxic factors, such as viruses, drugs, lipid deposition, and autoimmune responses, induce acute or chronic liver injury, and 3.5% of all...
SourceID doaj
pubmedcentral
proquest
gale
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 1
SubjectTerms Adenosine triphosphate
Analysis
Apoptosis
Autoimmunity
Autophagy
Bile
Biomedical and Life Sciences
Biomedical Engineering and Bioengineering
Cell adhesion & migration
Cell Biology
Cell death
Cell differentiation
Cell migration
Cell therapy
Cell-free
Chromatography
Cirrhosis
Cytokines
Deoxyribonucleic acid
Disease transmission
DNA
Extracellular vesicles
Graft rejection
Health aspects
Hepatocellular carcinoma
Hepatocytes
Homeostasis
Immunoregulation
Immunosuppressive agents
Ischemia
Kinases
Life Sciences
Lipids
Liver cancer
Liver cirrhosis
Liver diseases
Liver failure
Liver injury
Liver transplantation
Medical research
Mesenchymal stem cell
Mesenchymal stem cells
Nucleic acids
Organ donors
Paracrine signalling
Personal injuries
Physiological aspects
Proteins
Regenerative medicine
Regenerative Medicine/Tissue Engineering
Review
Secretome
Stem cell transplantation
Stem Cells
Transcription factors
Treatment
Tumorigenicity
Viral infections
SummonAdditionalLinks – databaseName: Directory of Open Access Journals (DOAJ)
  dbid: DOA
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LaxRBEG4kKHgRnzgaYyuCBx0yM93Tj9yiGPRgEB-QW9vTD7MhmZWdXSH_3qqehxmDevG2bNewu_Wu7aqvCHnGGfNcgqXZ2uucR7Q5rZuc4dxy5Hjk0rIJeXiojo70hwurvrAnrIcH7hm3ayECueB4o13Dq1ApF4UWulY2ZccBvW8h9YViKvlgKNMh2I5TMkrsdlB2gT1htVSUStd5OYtECbD_slu-3Cr5231pCkMHN8mNIX-k-_33vkWuhPY2udZvlDy_Q76-x2kid3x-BkSI0Uzxn_kcY5XvX8ZVCLRbjwgRe7SzMVDbetq3doD3o1P3eUchp6Wn2LtBF-0J8P8u-XLw5vPrt_mwRCF3sqzXuYcSKHDpg_aNqJCRVnHtpVZChcY6LWwUtlTWs1o1rIi68rUPLuIVn3eW3SNb7bIN9wn1EO6cF1WBd5Glq1QR6sbXjMdoeeVURsqRocYNCOO46OLUpEpDCdMLwYAQTBKCKTPyYnrme4-v8VfqVyiniRKxsdMboDFm0BjzL43JyGOUsukHTScLN_uQexW8lAXPyNNEgfgYLTbgfLObrjPvPn2cET0fiOISfqWzwzwD8AohtWaU2zNKMGA3Px7VzQwOpDOQdXHsmeU6I0-mY3wSm-LasNwkmgLiHON1RuRMTWcMmp-0i-MEIi650JUEmb0cFfrXh_9ZAA_-hwAekutVskOdF2ybbK1Xm_CIXHU_1otutZMM-ScxSUmm
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: SpringerLink
  dbid: RSV
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9QwFLZQAYkLOyJQwCAkDhCR2I5jcyuICg5UqAXUm3G8tINKBk1mkPrvec9ZUCggwW00_qyZvNUvfgshjwXnXtSgabbyOhcRdU7rJudYtxwFLrk0bKLe21OHh_r9UBTWjdnu45VkstRJrZV83kHcBAqB4U5RKl3lEPOcB3encGDD_sGn6c1KASE6ONqxQua3W2deKDXrP2uSz6ZJ_nJXmlzQ7pX_-_NXyeXhyEl3ehm5Rs6F9jq52A-hPL1BPr_DAiR3fPoVQNjWmeLL_Bzdm-8_xlUItFuPTSVe0M7GQG3raZ8NAgaTTgnrHYVjMD3BdA-6aL8Ay26Sj7uvP7x6kw9zF3JXl9U69xA1BVH7oH0jWXCisUpoX2slVWis09JGaUtlPa9Uw4uoma98cBFvBb2z_BbZapdtuE2oBw_pvGQFXl-WjqkiVI2vuIjRCuZURsqRD8YNTclxNsaJScGJkqannAHKmUQ5U2bk6bTnW9-S46_ol8jeCYnttNMXy9WRGbTTWDjmOHxQ7RrBAlMuSi11pWwKwUJGHqBwmL42dTIKZgeOa4Uo60Jk5FFCYEuNFnN2juym68zbg_0Z6MkAikt4SmeHEgigFXbhmiG3Z0jQeTdfHqXUDDanM3BQE5hmK3RGHk7LuBPz6Nqw3CRMAa6Riyoj9Uy6ZwSar7SL49R3vBZSsxp49myU8Z8__mcG3Pk3-F1yiSU10XnBt8nWerUJ98gF93296Fb3k6b_APGpTbg
  priority: 102
  providerName: Springer Nature
Title Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury
URI https://link.springer.com/article/10.1186/s13287-020-01895-1
https://www.proquest.com/docview/2444109049
https://www.proquest.com/docview/2440467345
https://pubmed.ncbi.nlm.nih.gov/PMC7469278
https://doaj.org/article/a812cec4b9cb42e28cf696958a02511e
Volume 11
WOSCitedRecordID wos000568563000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVADU
  databaseName: BioMedCentral
  customDbUrl:
  eissn: 1757-6512
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000330064
  issn: 1757-6512
  databaseCode: RBZ
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://www.biomedcentral.com/search/
  providerName: BioMedCentral
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1757-6512
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000330064
  issn: 1757-6512
  databaseCode: DOA
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1757-6512
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000330064
  issn: 1757-6512
  databaseCode: M~E
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 1757-6512
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000330064
  issn: 1757-6512
  databaseCode: M7P
  dateStart: 20150101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1757-6512
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000330064
  issn: 1757-6512
  databaseCode: 7X7
  dateStart: 20150101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1757-6512
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000330064
  issn: 1757-6512
  databaseCode: BENPR
  dateStart: 20150101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 1757-6512
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000330064
  issn: 1757-6512
  databaseCode: PIMPY
  dateStart: 20150101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVAVX
  databaseName: Springer Standard Collection
  customDbUrl:
  eissn: 1757-6512
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000330064
  issn: 1757-6512
  databaseCode: RSV
  dateStart: 20100301
  isFulltext: true
  titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22
  providerName: Springer Nature
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELfYBhIvfCMCoxiExANEy4cT27ygDW1iD6uqDlB5Mo7tbEUjHU2LtP-eO-djChN74aVq44tS57585_PvCHnN0tQyDpqmMytDVqLOSVmEKZ5bLhkOGd9sgo_HYjaTkzbhVrdllZ1N9IbaLgzmyHfADTEsImTyw_mvELtG4e5q20Jjg2whSkLiS_cmfY4lgmAdXG53VkbkOzUEX6BVGDNFsZBZGA_8kYftv2qcrxZM_rVr6p3Rwd3_ncY9cqddhtLdRm7ukxuuekBuNY0pLx6S70d4KMmcXvwEIoR6ppjgD9Hl2eZruXSO1qsOaOI9rXXpqK4sbSpEwIjSvoi9prA0pmdYAkLn1Q9g4yPy5WD_88dPYduLITQ8zlahhUjKMW6dtEWeOMMKLZi0XIpcuEIbmesy17HQNs1EkUalTGxmnSlxp9AanT4mm9Wick8IteA1jc2TCLc0Y5OIyGWFzVJWlpolRgQk7jiiTAtUjv0yzpQPWESuGi4q4KLyXFRxQN7295w3MB3XUu8ho3tKhNj2FxbLE9VqrNKw9DE4UWkKlrhEmDKXucyE9mGZC8gLFBPVnFftDYXahSVcxGIesYC88hQIs1FhHc-JXte1OjyeDojetETlAmZpdHssAt4VInMNKLcHlGAHzHC4kzjV2qFaXYpbQF72w3gn1tZVbrH2NBG4y5RlAeEDOR-8oOFINT_1WOSc5TLhwLN3nUZcPvzfDHh6_X99Rm4nXkVlGKXbZHO1XLvn5Kb5vZrXyxHZ4DPuP8WIbO3tjyfTkU-ljLz2w7XJ4dHkG_yaHn_9A4yQXrk
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFD4aHQheuCMCgxkE4gGi5eIkNhJC4zKt2lpVMKTx5Dm2sxWNdDQtqH-K34iPk3QKE3vbA29VfJLG9ndu8bkAPKNxrGlmOU0mmvu0QJ7jPPdjzFsuKA4p12wiGw7Z_j4frcDvNhcGwypbmegEtZ4o_Ea-YdUQxSBCyt-e_PCxaxSerrYtNGpY7JjFL-uyVW_6H-z-Po-irY9777f9pquAr7Iwmfna-gSGZtpwnaeRUTSXjHKdcZYyk0vFU1mkMmRSxwnL46DgkU60UQWeeWklY_vcS7BKEew9WB31B6Ovy686QRyjkm-zc1i6UVl3z_IxemlByHjihx0N6BoFnFUHZ0M0_zqndepv68b_tnA34XpjaJPNmjNuwYopb8OVuvXm4g4cDDDtSh0tvlsiLGZN8AjDR6Wu65_F1BhSzdpSGq9JJQtDZKlJHQNj1QRZhulXxBr_5BiDXMi4_GaBehe-XMj07kGvnJTmPhBt7QKl0yjAQ9tQRSwwSa6TmBaFpJFiHoQtAoRqSrFjR5Bj4VwylooaNcKiRjjUiNCDl8t7TupCJOdSv0NgLSmxiLi7MJkeikYmCWmNO4UT5SqnkYmYKlKe8oRJ53gaD9YRlqLOyF2KQrFpjdSAhllAPXjqKLCQSImRSodyXlWi__lTh-hFQ1RM7CyVbBI_7Fph7bEO5VqH0ko61R1uES4aSVuJU3h78GQ5jHdi9GBpJnNHE1iDIKaJB1mHrzoL1B0px0eu2npGUx5lds9etRx4-uf_3oAH57_rOlzd3hvsit3-cOchXIuceOB-EK9Bbzadm0dwWf2cjavp40bCEDi4aN78AyRTuUo
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Zb9QwELZQOcQLNyKlUIOQeICoORzH5q0cKypgVVFAfXMdH-2iNlttdpH675lxDggFJMRbFH9W5BnPFc-MCXnC8tyyEiRNF1bGzKPMSVnFOdYte4ZDJlw2UU6nYn9f7v5UxR-y3fsjybamAbs01cutU-tbERd8q4EYCoQDQ58kFbKIIf65yDCRHuP1vS_DX5YEwnUwun21zG-njixSaNx_Xj2fT5n85dw0mKPJ9f9fyA1yrXNF6Xa7d26SC66-RS63l1Oe3SYHH7AwyRydnQAI2z1T_Mkfo9mz7aNfOEebZd9s4gVttHdU15a2WSKgSOmQyN5QcI_pMaaB0Fn9FVh5h3yevPn06m3c3ccQmzItlrGFaMqx0jppK545wyotmLSlFFy4ShvJtec6FdrmhajyxMvMFtYZj6eF1uj8Llmr57W7R6gFy2kszxI81kxNJhJXVLbImfeaZUZEJO15okzXrBzvzDhWIWgRXLWUU0A5FSin0og8G-actq06_op-iawekNhmO7yYLw5VJ7VKg_tjcKHSVCxzmTCeSy4LoUNo5iKyiRtFtTWrg7JQ2-DGJSwtExaRxwGBrTZqzOU51KumUTt7H0egpx3Iz2GVRnelEUAr7M41Qm6MkKALzHi437Gq00WNAgeOYfotkxF5NAzjTMyvq918FTAJmMycFREpRzt9RKDxSD07Cv3IS8ZlVgLPnvf7_cfH_8yA9X-Db5Iru68n6v3O9N19cjULEiPjJN8ga8vFyj0gl8y35axZPAwK4DuPRVmA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mesenchymal+stem+cell-based+cell-free+strategies%3A+safe+and+effective+treatments+for+liver+injury&rft.jtitle=Stem+cell+research+%26+therapy&rft.au=Hu%2C+Chenxia&rft.au=Zhao%2C+Lingfei&rft.au=Zhang%2C+Lingjian&rft.au=Bao%2C+Qiongling&rft.date=2020-09-03&rft.pub=BioMed+Central+Ltd&rft.issn=1757-6512&rft.eissn=1757-6512&rft.volume=11&rft.issue=1&rft_id=info:doi/10.1186%2Fs13287-020-01895-1&rft.externalDocID=A635041704
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1757-6512&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1757-6512&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1757-6512&client=summon